Literature DB >> 20644166

The IFN-gamma-dependent suppressor of cytokine signaling 1 promoter activity is positively regulated by IFN regulatory factor-1 and Sp1 but repressed by growth factor independence-1b and Krüppel-like factor-4, and it is dysregulated in psoriatic keratinocytes.

Stefania Madonna1, Claudia Scarponi, Rosanna Sestito, Sabatino Pallotta, Andrea Cavani, Cristina Albanesi.   

Abstract

Epidermal keratinocytes can counteract the detrimental effects of IFN-gamma by inducing the expression of suppressor of cytokine signaling (SOCS)1, which plays an important anti-inflammatory and self-protective role. To date, limited information exists on its expression and regulation in human diseased keratinocytes. In this study, we compared the expression levels of SOCS1 in keratinocytes isolated from skin affected by psoriasis with cells obtained from healthy donors, unveiling that keratinocytes are more prone than healthy cells to upregulate SOCS1 mRNA expression in response to IFN-gamma. We explored the regulatory mechanisms involved in socs1 gene transcription, and found that Sp1 and IFN regulatory factor-1 transcription factors are, respectively, responsible for the basal and IFN-gamma-induced activity of human socs1 promoter. In parallel, we demonstrated that socs1 promoter is negatively regulated by two transcriptional repressors, namely, growth factor independence-1b and Krüppel-like factor 4, which tightly control SOCS1 transcription on IFN-gamma stimulation. Interestingly, although the expression of Sp1 and IFN regulatory factor-1 activators of socs1 promoter is unaltered, growth factor independence-1b and Krüppel-like factor 4 are significantly reduced in psoriatic compared with healthy keratinocytes. This reduction and the consequent unbalanced binding of transcriptional activators and repressors to socs1 promoter after IFN-gamma stimulation might be responsible for the enhanced expression of SOCS1 in psoriatic cells. We suggest that SOCS1 exaggerated upregulation in psoriatic keratinocytes could represent a mechanism through which these cells attempt to protect themselves from IFN-gamma effects. However, the SOCS1 increased levels in psoriatic keratinocytes are not sufficient to completely inhibit the expression of proinflammatory genes.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20644166     DOI: 10.4049/jimmunol.1001426

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  24 in total

1.  An IRF-3-, IRF-5-, and IRF-7-Independent Pathway of Dengue Viral Resistance Utilizes IRF-1 to Stimulate Type I and II Interferon Responses.

Authors:  Aaron F Carlin; Emily M Plummer; Edward A Vizcarra; Nicholas Sheets; Yunichel Joo; William Tang; Jeremy Day; Jay Greenbaum; Christopher K Glass; Michael S Diamond; Sujan Shresta
Journal:  Cell Rep       Date:  2017-11-07       Impact factor: 9.423

2.  Suppressor of Cytokine Signaling (SOCS)1 Regulates Interleukin-4 (IL-4)-activated Insulin Receptor Substrate (IRS)-2 Tyrosine Phosphorylation in Monocytes and Macrophages via the Proteasome.

Authors:  Sarah M McCormick; Nagaraj Gowda; Jessie X Fang; Nicola M Heller
Journal:  J Biol Chem       Date:  2016-08-09       Impact factor: 5.157

Review 3.  The Inflammatory Response in Psoriasis: a Comprehensive Review.

Authors:  Yaxiong Deng; Christopher Chang; Qianjin Lu
Journal:  Clin Rev Allergy Immunol       Date:  2016-06       Impact factor: 8.667

4.  Anti-apoptotic effects of suppressor of cytokine signaling 3 and 1 in psoriasis.

Authors:  S Madonna; C Scarponi; S Pallotta; A Cavani; C Albanesi
Journal:  Cell Death Dis       Date:  2012-06-28       Impact factor: 8.469

Review 5.  Comparative assessment of biologics in treatment of psoriasis: drug design and clinical effectiveness of ustekinumab.

Authors:  Ignacio Garcia-Valladares; Raquel Cuchacovich; Luis R Espinoza
Journal:  Drug Des Devel Ther       Date:  2011-01-10       Impact factor: 4.162

Review 6.  Complexity of Interferon-γ Interactions with HSV-1.

Authors:  Nancy J Bigley
Journal:  Front Immunol       Date:  2014-02-06       Impact factor: 7.561

Review 7.  Interferon-γ: teammate or opponent in the tumour microenvironment?

Authors:  Angela M Gocher; Creg J Workman; Dario A A Vignali
Journal:  Nat Rev Immunol       Date:  2021-06-21       Impact factor: 53.106

8.  Enhanced NAMPT-Mediated NAD Salvage Pathway Contributes to Psoriasis Pathogenesis by Amplifying Epithelial Auto-Inflammatory Circuits.

Authors:  Laura Mercurio; Martina Morelli; Claudia Scarponi; Giovanni Luca Scaglione; Sabatino Pallotta; Daniele Avitabile; Cristina Albanesi; Stefania Madonna
Journal:  Int J Mol Sci       Date:  2021-06-25       Impact factor: 5.923

9.  NF-κB is activated in response to temozolomide in an AKT-dependent manner and confers protection against the growth suppressive effect of the drug.

Authors:  Simona Caporali; Lauretta Levati; Grazia Graziani; Alessia Muzi; Maria Grazia Atzori; Enzo Bonmassar; Giuseppe Palmieri; Paolo A Ascierto; Stefania D'Atri
Journal:  J Transl Med       Date:  2012-12-21       Impact factor: 5.531

10.  Novel factors in the pathogenesis of psoriasis and potential drug candidates are found with systems biology approach.

Authors:  Máté Manczinger; Lajos Kemény
Journal:  PLoS One       Date:  2013-11-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.